Precigen
PGEN
#5421
Rank
โ‚น127.95 B
Marketcap
โ‚น361.65
Share price
-2.45%
Change (1 day)
138.38%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2025 (TTM): -โ‚น21.62 Billion

According to Precigen's latest financial reports the company's current earnings are โ‚น6.3 Million. In 2024 the company made an earning of -โ‚น11.64 Billion a decrease over its 2023 earnings that were of -โ‚น8.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น21.62 Billion85.78%
2024 -โ‚น11.64 Billion32.86%
2023 -โ‚น8.76 Billion20.5%
2022 -โ‚น7.27 Billion-23.33%
2021 -โ‚น9.48 Billion60.11%
2020 -โ‚น5.92 Billion-65.1%
2019 -โ‚น16.97 Billion-65.19%
2018 -โ‚น48.73 Billion313.44%
2017 -โ‚น11.79 Billion-33.2%
2016 -โ‚น17.65 Billion123.22%
2015 -โ‚น7.91 Billion1.47%
2014 -โ‚น7.79 Billion109.54%
2013 -โ‚น3.72 Billion-50.04%
2012 -โ‚น7.44 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚น0.23 Billion-98.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น6.64 Billion-70.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น34.07 B-251.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚น11.55 Billion-48.56% Jersey